Ys Biopharma Co, Stock Market Capitalization
YSDelisted Stock | 0.48 0.03 5.88% |
YS Biopharma Co, fundamentals help investors to digest information that contributes to YS Biopharma's financial success or failures. It also enables traders to predict the movement of YS Biopharma Stock. The fundamental analysis module provides a way to measure YS Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to YS Biopharma stock.
YS Biopharma |
YS Biopharma Co, Company Market Capitalization Analysis
YS Biopharma's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current YS Biopharma Market Capitalization | 192.09 M |
Most of YS Biopharma's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, YS Biopharma Co, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of YS Biopharma Co, is about 192.09 M. This is 98.52% lower than that of the Biotechnology sector and 95.95% lower than that of the Health Care industry. The market capitalization for all United States stocks is 98.99% higher than that of the company.
YS Biopharma Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses YS Biopharma's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of YS Biopharma could also be used in its relative valuation, which is a method of valuing YS Biopharma by comparing valuation metrics of similar companies.YS Biopharma is currently under evaluation in market capitalization category among its peers.
YS Biopharma Fundamentals
Return On Equity | -0.78 | |||
Return On Asset | -0.1 | |||
Profit Margin | (0.67) % | |||
Operating Margin | (0.49) % | |||
Current Valuation | 429.47 M | |||
Shares Outstanding | 188.33 M | |||
Shares Owned By Insiders | 81.42 % | |||
Shares Owned By Institutions | 2.85 % | |||
Number Of Shares Shorted | 38.89 K | |||
Price To Book | 2.10 X | |||
Price To Sales | 0.29 X | |||
Revenue | 687.2 M | |||
EBITDA | (76.82 M) | |||
Net Income | (145.48 M) | |||
Total Debt | 498.63 M | |||
Book Value Per Share | 5.10 X | |||
Cash Flow From Operations | (182.47 M) | |||
Short Ratio | 0.31 X | |||
Earnings Per Share | (0.56) X | |||
Target Price | 4.17 | |||
Number Of Employees | 773 | |||
Beta | 0.54 | |||
Market Capitalization | 192.09 M | |||
Total Asset | 1.72 B | |||
Retained Earnings | (1.87 B) | |||
Working Capital | 377.22 M | |||
Net Asset | 1.72 B |
About YS Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze YS Biopharma Co,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of YS Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of YS Biopharma Co, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in YS Biopharma Stock
If you are still planning to invest in YS Biopharma Co, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the YS Biopharma's history and understand the potential risks before investing.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |